Skip to main content
Year archive

Brainsway Ltd. — 2021 filings

All 65 regulatory filings released by Brainsway Ltd. (BWAY) in 2021, sourced directly from the official regulator.

65 Filings
2021 Period
2021 filings (65)
Filing Released Lang
Adopted Resolutions of Annual General Meeting
AGM Information
2021-12-23 English
Adopted Resolutions of Annual General Meeting
AGM Information
2021-12-23 English
BrainsWay Announces Publication of Deep TMS™ Trial Results for Reduction of Heavy Drinking in Alcohol-Dependent Subjects
Regulatory Filings
2021-12-09 English
BrainsWay Announces Publication of Deep TMS™ Trial Results for Reduction of Heavy Drinking in Alcohol-Dependent Subjects
Earnings Release FY 2021
2021-12-09 English
OTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS To Be Held on December 22, 2021
AGM Information
2021-11-17 English
OTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS To Be Held on December 22, 2021
Proxy Solicitation & Information Statement
2021-11-17 English
OTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS To Be Held on December 22, 2021
AGM Information
2021-11-17 English
OTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS To Be Held on December 22, 2021
AGM Information
2021-11-17 English
Reports Third Quarter 2021 Financial Results
Interim / Quarterly Report Q3 2021
2021-11-17 English
Reports Third Quarter 2021 Financial Results
Report Publication Announcement
2021-11-17 English
FORM F-3 - SHELF REGISTRATION
Capital/Financing Update
2021-09-19 English
FORM F-3 - SHELF REGISTRATION
Regulatory Filings
2021-09-19 English
FDA Clears BrainsWay Deep TMS™ System for Decreasing Anxiety Symptoms in Depressed Patients,Expanded Depression Indication Further Demonstrates Company’s Leadership Position
Regulatory Filings
2021-08-18 English
FDA Clears BrainsWay Deep TMS™ System for Decreasing Anxiety Symptoms in Depressed Patients,Expanded Depression Indication Further Demonstrates Company’s Leadership Position
Report Publication Announcement
2021-08-18 English
FORM 6-K-Reports Second Quarter 2021 Financial Results
Interim / Quarterly Report Q2 2021
2021-08-11 English
FORM 6-K-Reports Second Quarter 2021 Financial Results
Report Publication Announcement
2021-08-11 English
FORM 20-F/A
Annual Report FY 2020
2021-06-17 Hebrew (modern)
FORM 20-F/A
Report Publication Announcement
2021-06-17 English
Completion of Options Exchange Offer
Regulatory Filings
2021-06-03 English
Completion of Options Exchange Offer
Report Publication Announcement
2021-06-03 English
SCHEDULE TO - Offer to Exchange Eligible Options for New Options - Amendment No. 1
M&A Activity
2021-06-03 English
SCHEDULE TO - Offer to Exchange Eligible Options for New Options - Amendment No. 1
Report Publication Announcement
2021-06-03 English
Announces Positive OCD Coverage Policy by Blue Cross Blue Shield Licensee HCSC
Regulatory Filings
2021-06-02 English
Announces Positive OCD Coverage Policy by Blue Cross Blue Shield Licensee HCSC
Regulatory Filings
2021-06-02 English
Announces First Draft Proposal for OCD Coverage by a Regional Medicare Administrative Contractor
Regulatory Filings
2021-06-01 English
Announces First Draft Proposal for OCD Coverage by a Regional Medicare Administrative Contractor
Report Publication Announcement
2021-06-01 English
Announces First of its Kind Coverage Policy by Centene for the Treatment of OCD Utilizing Deep TMS
Regulatory Filings
2021-05-24 English
Announces First of its Kind Coverage Policy by Centene for the Treatment of OCD Utilizing Deep TMS
Regulatory Filings
2021-05-24 English
BrainsWay Updates Line Item in 2021 First Quarter Financial Results
Regulatory Filings Q1 2021
2021-05-24 English
BrainsWay Updates Line Item in 2021 First Quarter Financial Results
Report Publication Announcement
2021-05-24 English
Reports First Quarter 2021 Financial Results and Operational Highlights
Interim / Quarterly Report Q1 2021
2021-05-20 English
Reports First Quarter 2021 Financial Results and Operational Highlights
Earnings Release Q1 2021
2021-05-20 English
Appointment of R. Scott Areglado as Senior Vice President and Chief Financial Officer
Board/Management Information
2021-05-05 English
Appointment of R. Scott Areglado as Senior Vice President and Chief Financial Officer
Board/Management Information
2021-05-05 English
Offer to Exchange Eligible Options for New Options
Proxy Solicitation & Information Statement
2021-05-04 English
Offer to Exchange Eligible Options for New Options
Report Publication Announcement
2021-05-04 English
Receives FDA Clearance for Three Minute Theta Burst Depression Treatment Protocol
Regulatory Filings
2021-04-26 English
Receives FDA Clearance for Three Minute Theta Burst Depression Treatment Protocol
Regulatory Filings
2021-04-26 English
BrainsWay 2020 Form 20-F
Annual Report FY 2020
2021-04-19 English
BrainsWay 2020 Form 20-F
Report Publication Announcement
2021-04-19 English
Fourth Quarter and Full-Year 2020 Financial Results,Conference call to be held tomorrow, March 25, 2021-amendment of clerical error
Earnings Release FY 2020
2021-03-25 English
Fourth Quarter and Full-Year 2020 Financial Results,Conference call to be held tomorrow, March 25, 2021-amendment of clerical error
Report Publication Announcement
2021-03-25 English
Fourth Quarter and Full-Year 2020 Financial Results and Operational Highlights
Earnings Release Q4 2020
2021-03-24 English
Fourth Quarter and Full-Year 2020 Financial Results and Operational Highlights
Report Publication Announcement
2021-03-24 English
Adopted Proposals of Annual General Meeting of Shareholders that was held on March 4, 2021
AGM Information
2021-03-04 English
Adopted Proposals of Annual General Meeting of Shareholders that was held on March 4, 2021
AGM Information
2021-03-04 English
Announces Closing of $45.2 Million Underwritten Public Offering
Capital/Financing Update
2021-03-01 English
Announces Closing of $45.2 Million Underwritten Public Offering
Capital/Financing Update
2021-03-01 English
Underwriting Agreement
Regulatory Filings
2021-02-25 English
Underwriting Agreement
Report Publication Announcement
2021-02-25 English
PROSPECTUS SUPPLEMENT To Prospectus dated October 16, 2020
Regulatory Filings
2021-02-24 English
Announces Pricing of $39,287,000 Underwritten Offering of American Depositary
Regulatory Filings
2021-02-23 English
Announces Pricing of $39,287,000 Underwritten Offering of American Depositary
Capital/Financing Update
2021-02-23 English
Trading in the company's securities was halted until the completion of pricing in U.S.
Regulatory Filings
2021-02-23 Hebrew (modern)
Announces Proposed Public Offering of American Depositary Shares
Capital/Financing Update
2021-02-22 English
Announces Proposed Public Offering of American Depositary Shares
Regulatory Filings
2021-02-22 English
PRELIMINARY PROSPECTUS SUPPLEMENT dated February 22, 2021
Capital/Financing Update
2021-02-22 English
PRELIMINARY PROSPECTUS SUPPLEMENT dated February 22, 2021
Regulatory Filings
2021-02-22 English
CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2020
Interim / Quarterly Report 9M 2020
2021-02-22 English
CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2020
Report Publication Announcement 9M 2020
2021-02-22 English
Reports Preliminary Fourth Quarter Revenue and Full Year 2020 Financials
Earnings Release Q4 2020
2021-02-16 English
Reports Preliminary Fourth Quarter Revenue and Full Year 2020 Financials
Report Publication Announcement
2021-02-16 English
Notice of annual general meeting of shareholders to be held on March 4, 2021
Proxy Solicitation & Information Statement
2021-01-27 English
Notice of annual general meeting of shareholders to be held on March 4, 2021
AGM Information
2021-01-27 English
Notice of annual general meeting of shareholders to be held on March 4, 2021
AGM Information
2021-01-27 English